Role of insulin-like growth factor I in maintaining normal glucose homeostasis

Hormone Research

Volumn 62, Issue SUPPL. 1, 2004, Pages 77-82

  Clemmons, David R ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

Adults; Diabetes mellitus; Gene polymorphisms; Glucose metabolism; Growth hormone; Insulin sensitivity; Insulin like growth factor I

Indexed keywords

FAT; GLUCOSE; INSULIN; INSULIN RECEPTOR; SOMATOMEDIN C; SOMATOMEDIN C RECEPTOR;

CONFERENCE PAPER; DIABETES MELLITUS; DISEASE SEVERITY; DOSE RESPONSE; DRUG EFFECT; EXPERIMENTAL MODEL; GENE DELETION; GENETIC ANALYSIS; GENETIC POLYMORPHISM; GLUCOSE BLOOD LEVEL; GLUCOSE HOMEOSTASIS; GLUCOSE METABOLISM; GLUCOSE TOLERANCE; GLUCOSE TRANSPORT; HEMOCONCENTRATION; HUMAN; INSULIN DEFICIENCY; INSULIN RELEASE; INSULIN RESISTANCE; INSULIN SENSITIVITY; INSULIN TREATMENT; LIVER; MOLECULE; MUSCLE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PATIENT; PORTAL VEIN; PREVALENCE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN BLOOD LEVEL; PROTEIN FUNCTION; PROTEIN STRUCTURE; PROTEIN SYNTHESIS; RECEPTOR BINDING; SEQUENCE ANALYSIS; SEQUENCE HOMOLOGY; SIGNAL TRANSDUCTION; STRUCTURE ANALYSIS; TISSUE SPECIFICITY;

ADULT; ANIMALS; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; GENE DELETION; GLUCOSE; HOMEOSTASIS; HUMANS; INSULIN; INSULIN RESISTANCE; INSULIN-LIKE GROWTH FACTOR I; MICE;

EID: 17244369621     PISSN: 03010163     EISSN: None     Source Type: Journal    
DOI: 10.1159/000080763     Document Type: Conference Paper

References (18)

1. Boni-Schnetzler M, Schmid C, Meier PJ, Froesch ER: Insulin regulates insulin-like growth factor I mRNA in rat hepatocytes. Am J Physiol 1991;260:E846-E851.
2. Seely BL, Reichart DR, Takata Y, Yip C, Olefsky JM: A functional assessment of insulin/insulin-like growth factor-I hybrid receptors. Endocrinology 1995;136:1635-1641.
3. Sakai K, Lowman HB, Clemmons DR: Increases in free, unbound insulin-like growth factor I enhance insulin responsiveness in human hepatoma G2 cells in culture. J Biol Chem 2002;277:13620-13627.
4. Dimitridas G, Parry-Billings M, Bevan S, Dunger D, Piva T, Krause U, Wegener G, Newsholme EA: Effects of insulin-like growth factor-I on the rates of glucose transport and utilization in rat skeletal muscle in vitro. Biochem J 1992;285:269-274.
5. Fernandez AM, Kim JK, Yakar S, Dupont J, Hernandez-Sanchez C, Castle AL, Filmore J, Shulman GI, Le Roith D: Functional inactivation of the IGF-I and insulin receptors in skeletal muscle causes type 2 diabetes. Genes Dev 2001;15:1926-1934.
6. Dominici FP, Cifone D, Bartke A, Turyn D: Loss of sensitivity to insulin at early events of the insulin signaling pathway in the liver of growth hormone-transgenic mice. J Endocrinol 1999;161:383-392.
7. Bereket A, Lang CH, Blethen SL, Gelato MC, Fan J, Frost RA, Wilson TA: Effect of insulin on the insulin-like growth factor system in children with new-onset insulin-dependent diabetes mellitus. J Clin Endocrinol Metab 1995;80:1312-1317.
8. Pao CI, Farmer PK, Begovic S, Goldstein S, Wu GJ, Phillips LS: Expression of hepatic insulin-like growth factor-I and insulin-like growth factor-binding protein-1 genes is transcriptionally regulated in streptozotocin-diabetic rats. Mol Endocrinol 1992;6:969-977.
9. Shishko PI, Dreval AV, Abugova IA, Zajarny IU, Goncharov VC: Insulin-like growth factors and binding proteins in patients with recent-onset type 1 (insulin-dependent) diabetes mellitus: influence of diabetes control and intraportal insulin infusion. Diabetes Res Clin Pract 1994;25:1-12.
10. Woods KA, Camacho-Hubner C, Bergman RN, Barter D, Clark AJ, Savage MO: Effects of insulin-like growth factor I (IGF-I) therapy on body composition and insulin resistance in IGF-I gene deletion. J Clin Endocrinol Metab 2000;85:1407-1411.
11. Kuzuya H, Matsuura N, Sakamoto M, Makino H, Sakamoto Y, Kadowaki T, Suzuki Y, Kobayashi M, Akazawa Y, Nomura M: Trial of insulinlike growth factor I therapy for patients with extreme insulin resistance syndromes. Diabetes 1993;42:696-705.
12. Yakar S, Liu JL, Fernandez AM, Wu Y, Schally AV, Frystyk J, Chernausek SD, Mejia W, Le Roith D: Liver-specific IGF-1 gene deletion leads to muscle insulin insensitivity. Diabetes 2001;50:1110-1118.
13. Haluzik M, Yakar S, Gavrilova O, Setser J, Boisclair Y, LeRoith D: Insulin resistance in the liver-specific IGF-1 gene-deleted mouse is abrogated by deletion of the acid-labile subunit of the IGF-binding protein-3 complex: relative roles of growth hormone and IGF-1 in insulin resistance. Diabetes 2003;52:2483-2489.
14. Crossey PA, Jones JS, Miell JP: Dysregulation of the insulin/IGF binding protein-1 axis in transgenic mice is associated with hyperinsulinemia and glucose intolerance. Diabetes 2000;49:457-465.
15. Moses AC, Young SC, Morrow LA, O'Brien M, Clemmons DR: Recombinant human insulin-like growth factor I increases insulin sensitivity and improves glycemic control in type II diabetes. Diabetes 1996;45:91-100.
16. RH IGF-I in NIDDM Study Group: Evidence from a dose ranging study that recombinant insulin-like growth factor-I (RhIGF-I) effectively and safely improves glycemic control in non-insulin dependent diabetes mellitus. Diabetes 1996;45(suppl 2):27A.
17. Vaessen N, Janssen JA, Heutink P, Hofman A, Lamberts SW, Oostra BA, Pols HA, van Duijn CM: Association between genetic variation in the gene for insulin-like growth factor-I and low birthweight. Lancet 2002;359:1036-1037.
18. Vaessen N, Heutink P, Janssen JA, Witteman JC, Testers L, Hofman A, Lamberts SW, Oostra BA, Pols HA, van Duijn CM: A polymorphism in the gene for IGF-I: functional properties and risk for type 2 diabetes and myocardial infarction. Diabetes 2001;50:637-642.